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Abstract 
Review on NDC80, and where the gene is 
implicated. 
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The human NDC80 gene lies on the  p arm of 
chromosome 18, close to the telomeric region; 
Position  2,571,511 to 2,616,635, forward strand 
(Ensembl ID: ENSG00000080986). 
Transcription 
The full mRNA comprises 2172 bp (Ensembl ID: 
ENST00000261597.8). The transcript contains 17 
exons. Ensembl reports the existence of 5 splice 
variants. Analysis of the 5'-flanking region showed 
that it contains binding sites for cAMP 
responsiveelement binding (CREB) and activating 
transcription factor 4 (ATFA or CREB 2) proteins 
that positively regulate transcription (Cheng et al, 
2007). 
Pseudogene 
No pseudogenes are described in humans. 
Protein 
Description 
642 aa; 73.9 kDa. 
"Highly Expressed in Cancer protein 1" (Hec1) is the 
name of the human homologue of the Ndc80 protein. 
It was originally identified as an interactor of the 
retinoblastoma (pRb) protein in the yeast two-hybrid 
system (Chen et al, 1997). It was subsequently re-
isolated as an interactor of the mitotic checkpoint 
protein MAD1L1 (Martin-Lluesma et al, 2002). 
Hec1 interacts with three other kinetochore proteins 
( NUF2, SPC25 and SPC24 ) to form the Ndc80 
kinetochore complex that is required for establishing 
stable interactions between the kinetochore and 
microtubules (Ciferri et al, 2005; DeLuca et al, 2006; 
DeLuca & Musacchio, 2012). The complex has an 
elongated rod-like structure that spans ~60 nm, with 
globular domains at both ends. The globular domains 
of Nuf2 and Hec1 interact with the microtubules at 
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one end whereas the Spc24-Spc25 globular heads 
constitute the centromere binding domain of the 
complex 
The crystal structure of a truncated version of the 
Ndc80 complex has been resolved and different 
Hec1 structural domains have been identified 
(Ciferri et al, 2008). The N-terminus comprises an 
unstructured tail domain (aa 1-80) which is highly 
basic and positively charged. The Hec1 tail is 
required for the efficient formation of stable 
kinetochore-microtubule attachments in mammalian 
cultured cells (Guimaraes et al, 2008; Miller et al, 
2008) and the affinity for microtubules of the entire 
complex is modulated by AURKB (Aurora B)-
mediated phosphorylation on Ser8, Ser44, Ser15, 
Ser55 residues within the tail domain 
A second portion of the N terminus folds into a 
Calponin Homology (CH) domain (aa 81-196), a 
motif found in actin- and microtubule-binding 
proteins. The CH domain contributes to microtubule 
binding and attachment stability through a direct 
interaction between a positively charged regionin the 
CH domain and a negative region at the alpha and 
beta tubulin interface on microtubules (Alushin et al, 
2010). Within the CH domain, Ser165 is 
phosphorylated by the mitotic NEK2 (NEK2A) 
kinase and expression of a non -phosphorylatable 
Hec1 has been shown to perturb chromosome 
congression and increase the number of erroneous 
kinetochore-microtubule interactions (Du et al, 
2008). 
The long coiled-coil region (aa 261-445) interacts 
with a similar region of Nuf2 producing the 
elongated rod-like structure. This domain is 
interrupted by a loop region in Ndc80 (aa 426-459), 
forming a kink in the Ndc80 complex structure. This 
region is required to establish end-on microtubule 
attachments to kinetochores through the binding of 
the spindle and kinetochore associated (Ska) 
complex and the Ctd1 replication licensing factor 
(Wan et al, 2009; Zhang et al, 2012; Varma et al, 
2012). Finally, the C terminus (446-642) takes part 
in a tetramerization domain where the 
Ndc80/Nuf2and Spc24/Spc25 dimers interact 
(Ciferri et al, 2005). 
Expression 
The protein is present in actively proliferating tissues 
such as testis, spleen and thymus in mice (Chen et al, 
1997). Hec1 expression is cell cycle regulated. In 
both untransformed and cultured cancer cells, the 
protein appears in late S and remains at high levels 
until mitosis, when it is down-regulated through 
anaphase promoting complex/cyclosome-Cdh1 
(APC/C-Cdh1) and proteasome-mediated 
degradation  (Li et al, 2011; Ferretti et al, 2010). 
Localisation 
Hec1 is a mitotic kinetochore protein. It localizes to 
nuclei in S phase and G2 cells. At the beginning of 
mitosis the protein localizes to the outer layer of the 
kinetochore (Wan et al, 2009), where it persists until 
it is degraded at the end of mitosis (Figure 1). 
 
Fig 1. Hec1 localization in human cells. Immunofluorescence images of HeLa cells stained with DAPI 
(blue) and anti-Hec1 antibody (red). Hec1 is nuclear in interphase G2 cells, localizes to kinetochores 
at all mitotic stages and is degraded from kinetochores at telophase. 
 
Function 
Kinetochore-microtubule interactions:  
Faithful chromosome segregation occurs when the 
two sister kinetochores are connected to 
microtubules emanating from different spindle poles 
(amphitelic attachment). However, in the early 
stages of mitosis non functional kinetochore-
microtubule interactions (syntelic and merotelic 
attachments) intervene and must be corrected before 
anaphase to impede chromosome mis-segregation 
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and aneuploidy (Cimini & Degrassi, 2005). Hec1 is 
a constituent of the evolutionary conserved 
Ndc80/Hec1 complex that mediates the attachment 
of sister chromatids to the mitotic spindle and is 
therefore implicated in producing amphitelic end-on 
attachments and directing chromosome movements 
during mitosis (Tooley & Stukenberg, 2011). 
Molecular affinity beetween Hec1 and microtubules 
is mediated by electrostatic interactions involving 
positively charged amino acid residues on the Hec1 
tail and CH domain that interact with negatively 
charged residues on microtubules (Ciferri et al, 
2008; Sundin et al, 2011; Tooley et al, 2011). 
Consequently, the temporally regulated 
phosphorylation of Hec1 N terminal tail by Aurora 
B kinase during prometaphase decrease the affinity 
of the Ndc80 complex to microtubules, allowing the 
detachment of erroneous kinetochore-microtubule 
interactions and enabling the formation of new 
correct attachments (Zaytsev et al, 2014; DeLuca et 
al, 2011). Phosphorylation by NEK2A kinase of the 
CH domain also contributes to this process. Finally, 
kinetochore-microtubule attachments are stabilized 
by the recruitment of the Ska complex and Cdt1 at 
the Ndc80 internal loop to form functional end-on 
attachments (Zhang et al, 2012; Varma et al, 2012). 
Mitotic checkpoint signaling:  
Several pieces of evidence indicate that Hec1 plays 
a positive role in the spindle assembly checkpoint 
(SAC). This conserved cellular mechanism inhibits 
anaphase onset until all kinetochores are 
amphitelically attached to the microtubules and 
inter-kinetochore tension is present. Unattached 
kinetochores recruit SAC components that are then 
released from kinetochores to inhibit the anaphase 
promoting complex/cyclosome necessary for sister 
chromatid separation and mitotic exit (Musacchio, 
2015). The Ndc80 complex is a structural component 
of the kinetochore and is required for proper SAC 
control as it recruits the ZW10 complex (Lin et al, 
2006; Kops et al, 2005) that is essential for the 
binding of the master checkpoint proteins MAD1L1 
and MAD2L1 to kinetochore (Martin-Lluesma et al, 
2002; DeLuca et al, 2003). Furthermore, Hec1 has 
been shown to specify the kinetochore localization 
of the checkpoint kinase TTK (Mps1) via its 
microtubule binding domain (Stucke et al, 2004; Zhu 
et al, 2013). Hec1 phosphorylation by Aurora B 
kinase weakens the kinetochore-microtubule 
interaction but promotes Hec1 binding to Mps1, 
suggesting a concerted regulation between 
kinetochore attachment and checkpoint signaling 
(Zhu et al, 2013; Hiruma et al, 2015). Significantly, 
recent work has shown that formation of stable 
kinetochore- microtubule attachments, irrespective 
of inter-kinetochore tension, is sufficient to satisfy 
the SAC in human cells (Tauchman et al, 2015) 
Implicated in 
Various Cancer 
Ndc80/Hec1 is a constituent of the NDC80 complex. 
The complex is required for accurate chromosome 
segregation in mitosis, as it is essential for 
generating bipolar end-on kinetochore-microtubule 
attachments, which are responsible for the faithful 
anaphase segregation of sister chromatids (DeLuca 
& Musacchio, 2012). Chromosome mis-segregation 
results in genome instability, which is a hallmark of 
cancer. The crucial role of the NDC80 complex in 
chromosome segregation during mitosis, the 
recurrent HEC1 upregulation in different human 
cancers (as described in sections below) and its 
dependence on pRb deficiency (Ferretti et al, 2010) 
suggest that Hec1 deregulation may be an important 
step in the multistage process of tumorigenesis. 
Concordantly, Hec1 depletion by RNa interference 
(RNAi) leads to defective mitotic checkpoint 
signaling, defective chromosome alignment to the 
metaphase plate and massive chromosome mis-
segregation and apoptosis (Martin-Lluesma et al, 
2002; Kaneko et al, 2009; Mattiuzzo et al, 2011; 
Linton et al, 2014; Ju et al, 2017). Interestingly, Hec1 
overexpression in an inducible mouse model has 
been shown to promote chromosome instability in 
embryonic fibroblasts and tumor formation in 
different mouse tissues (Diaz-Rodriguez et al, 2008). 
Moreover, NDC80 is one of the genes defining a 11 
gene signature associated with poor prognosis in 
multiple cancer types (Glinsky et al, 2005). This 
signature identifies a metastasis-enabling, anoikis-
resistant, aneuploid-prone phenotype (Glinsky, 
2006). 
Breast Cancer 
A real-time reverse transcription polymerase chain 
reaction (RT-PCR) study investigated expression of 
76 mitotic spindle checkpoint genes in a large panel 
of breast tumor samples (including normal breast 
tissues, benign breast tumors, ductal carcinoma in 
situ, and grade I and III invasive ductal breast 
tumors). The study identified NDC80/Hec1 as one of 
the genes markedly upregulated in ductal grade III 
breast tumors. More interestingly, Ndc80 was 
specifically involved in the transition from normal 
breast tissues to benign breast tumors. Indeed, it was 
found as the most strongly upregulated gene in 
benign breast tumors, being its levels > 3-fold higher 
in begnin tumors than in normal breast tissues 
(Bièche et al, 2011). Moreover, NDC80 is part of 
several multigene expression profiles, which are 
commonly used in clinical settings to characterize 
breast cancer tissues for individualization of therapy 
(Koleck Conley, 2016).  
 
A study on the relationships between host single-
nucleotide polymorphisms (SNPs) and pretreatment 
cognitive performance in post-menopausal women 
diagnosed with early stage breast cancer has 
identified Ndc80 as one of 22 genes with a positive 
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association between host polymorphisms and 
improvement in cognitive function performance 
(Koleck et al, 2017). 
Pancreatic Cancer 
NDC80 mRNA and protein have been found 
overexpressed in pancreatic cancer tissues and in 
pancreatic cancer cell lines (Meng et al, 2015). 
Immunohistochemical evaluation of human 
pancreatic cancer tissues suggested that Ndc80 
overexpression is significantly associated with 
clinicopathological parameters, including 
pathological T staging and N staging, which are 
predictors of poor prognosis (Meng et al, 2015). 
Liver Cancer 
NDC80 expression has been analyzed by RT-PCR in 
42 paired hepatocellular carcinoma (HCC) and 
adjacent tissues. The study has revealed that NDC80 
levels are significantly higher in HCC cells as 
compared with adjacent tissues (Ju et al, 2017). A 
gene expression profile dataset of 10 HCC and 10 
control samples analysed for gene ontology has 
identified NDC80 as member of a group of cell 
division-related genes that are up-regulated in HCC. 
Moreover, Ndc80 has been identified as an "hub" 
protein in HCC cancer, as revealed by protein-
protein interaction network construction and module 
detection using the STRING online tool (Yan et al, 
2017). 
Gastric Cancer 
mRNA overexpression of the four genes comprising 
the Ndc80 complex has been  observed in primary 
resected gastric cancers when compared with the 
corresponding normal mucosae (Kaneko et al, 2009).  
More recently, RT-PCR and immunohistochemical 
staining of 42 gastric cancer and paired non-cancer 
tissues showed higher expression of both Hec1 
mRNA and protein in gastric cancers as compared 
with non-tumor tissues. Hec1 staining was observed 
in 90% of cancer samples whereas positive staining 
was rarely observed in non cancer tissues. Positive 
staining of Hec1 was also observed in dysplasia 
glands, a precancerous lesion, suggesting an 
important role of Hec1 in the early stage of gastric 
tumorigenesis (Qu et al, 2014). 
Prostate Cancer 
Hec1 mRNA overexpression has been detected in 
human Prostate Cancer (PCa) tissues and higher 
mRNA and protein levels have been found in several 
PCa cell lines  (Wang et al, 2015). The same study 
has also identified a long-non-coding RNA 
(LncRNA BX647187) as up-regulated in human PCa 
tissues and cell lines. The study also showed that 
LncRNA levels are positively regulated by Hec1, as 
they were strongly reduced upon Hec1 depletion. 
Interestingly, suppression of BX647187 
significantly reduced cell proliferation and promoted 
apoptosis of PCa cells (Wang et al, 2015). 
Colon cancer 
Overexpression of Ndc80 mRNA has been reported 
in colorectal cancer tissues (Kaneko et al, 2009; 
Miyata et al, 2015).  High levels of Ndc80 protein 
have been also observed in several colon cancer cell 
lines (Xing et al, 2016). Immunohistochemical 
analysis on tissue samples demonstrated that the rate 
of Ndc80-positive cells was significantly higher in 
colon cancer specimens than in normal colon tissues. 
Faster cell proliferation and greater migration ability 
was observed in colorectal SW480 cells transfected 
with an Ndc80-expressing vector as compared to 
controls (Xing et al, 2016). 
Oligodendrogliomas 
A study of microarray and RNA sequencing on 
normal brain tissue as compared to grade II and III 
oligodendrogliomas (ODs) has identified a co-
expression network of six mitosis-regulating genes 
(NDC80 is among these) associated with malignant 
progression and prognosis in ODs. Validation by 
quantitative PCR of the six gene network has been 
obtained in a second group of ODs patients. (Liu et 
al, 2015). 
Lung Cancer 
Co-overexpression of Nuf2 and Ncd80, members of 
the evolutionarily conserved centromere protein 
complex (Ndc80), has been found in non-small cell 
lung carcinomas (NSCLC) and NSCLC cell lines 
(Hayama et al, 2006). Immunohistochemical 
analysis using lung cancer tissue microarray 
confirmed high levels of the two proteins in the great 
majority of lung cancers of various histological types 
(Hayama et al, 2006). The same study demonstrated 
that NSCLC patients with abundant expression of 
Nuf2/Ndc80 experience a shorter tumor-specific 
survival period (Hayama et al, 2006). 
Ovarian Cancer 
A RNA interference lethality screen of the human 
druggable genome has identified NDC80 among the 
four genes with a role in growth or survival of 
ovarian cancer cell lines. The study demonstrated 
that ovarian tumorigenic cells are comparatively 
more vulnerable to Ndc80 down-regulation 
compared with non-tumorigenic cells. Finally, 
Ndc80 was found overexpressed in nearly 100% of 
the samples in two independent cohorts of patient 
samples (Sethi et al, 2012). 
Endometrial Cancer 
A study of cDNA microarray has identified NDC80 
as an up-regulated gene in serous endometrial 
adenocarcinomas. NDC80 was found to be member 
of a cluster of 46 genes exhibiting >2-fold 
differences in expression between serous 
endometrial adenocarcinomas and 
endometrioidones.  Quantitative PCR and 
immunohistochemistry for Ndc80 confirmed the 
array results. Using unsupervised and supervised 
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statistical analyses, this gene cluster has been 
demonstrated to statistically differentiate the two 
types of adenocarcinomas (Chen et al, 2011). 
To be noted 
Note 
Aneuploidy and chromosome instability are strongly 
involved in tumorigenesis. It has been demonstrated 
that aneuploidy may also act as a tumor suppressive 
mechanism, depending on the tissue analyzed and its 
intrinsic chromosome instability (Weaver et al. 
2007; Janssen and Medema 2013).  
 
Since the crucial role of Hec1 in chromosome 
segregation, it represents a promising molecular 
target for developing new therapeutic approaches 
and molecules that exert their anticancer property by 
producing massive aneuploidy and cell death in 
cancer cells. Concordantly, expression of a Hec1 
protein modified at its N-terminus, the region of 
interaction with microtubules, has been shown to 
massively kill cancer cells both in vitro and in tumor 
xenografts (Orticello et al, 2014; Mattiuzzo et al, 
2011).  
 
Several RNAi studies have provided direct 
demonstration of the anti-proliferative effects of 
Hec1 inactivation in cancer cell lines  from different 
tumor types such as mesothelioma (Linton et al, 
2014), NSCLC (Hayama et al, 2006), prostate 
(Wang et al, 2015), gastric (Qu et al, 2014), 
hepatocellular (Ju et al., 2015) or pancreatic  cancer 
(Meng et al, 2015). Hec1 depletion by RNAi has also 
been found to inhibit tumor growth in mouse 
xenografts (Gurzov & Izquierdo, 2006; Li et al, 
2007).  
 
In the recent years, several approaches have been 
undertaken to target Hec1 by inhibitory small 
molecules. Given the role of the NEK2A-dependent 
phosphorylation of Hec1 in the SAC, small 
molecules capable of disturbing NEK2A-Hec1 
interaction have been identified and optimized by 
different groups (Wu et al, 2008; Lee et al, 2014; 
Huang et al, 2014a).  In a different approach, a 
virtual screening for small molecules able to bind at 
the Hec1-microtubule interaction surface has been 
undertaken (Ferrara et al, 2017). This study 
identified a small molecule that produces 
chromosome segregation defects in cancer cells and 
promotes cancer cell death through mitotic 
catastrophe (Ferrara et al, 2017) In both approaches, 
the identified small molecules significantly reduced 
tumor growth in xenograft models (Huang et al, 
2014b; Wu et al, 2008; Ferrara et al, 2017). 
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